北美自体输血设备市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（产品和配件）、应用（心脏手术、骨科手术、器官移植、创伤手术等）和最终用户（医院、专科诊所）和门诊手术中心）
No. of Pages: 131 | Report Code: TIPRE00009996 | Category: Life Sciences
No. of Pages: 131 | Report Code: TIPRE00009996 | Category: Life Sciences
器官移植是一种外科手术如果器官衰竭。通常，器官移植是针对心脏、肝脏、肾脏等器官进行的；然而，随着慢性病病例的增加，其他器官如肺、胰腺、角膜和血管组织也需要移植。这些手术通常需要数小时，并且会产生大量失血，而自体输血是防止失血的宝贵方法之一。根据联合国器官共享网络 (UNOS) 的数据，美国进行的器官移植数量不断增加，2021 年进行了超过 41,000 例移植手术。同样，加拿大每百万人口有 22.2 名捐献者，并且正在稳步改善，部分原因是“捐献医生”人物——负责器官捐献的重症监护医生。与移植协调员合作的公私伙伴关系为改善器官移植做出了重大贡献。发展中国家和发达国家的器官移植手术都有所增加。各国在提供更好、更先进的医疗方面正在取得进展。因此，器官移植需求的不断增长是推动自体输血设备等移植诊断需求的关键因素之一。
北美自体输血设备市场根据类型、应用、最终用户和国家/地区进行细分。市场按类型分为产品和配件。 2021年，配件细分市场占有更大的市场份额。该产品细分市场进一步细分为术中自体输血系统、术后自体输血系统和双模式自体输血系统。 2021年，术中自体输血系统领域占据最大的市场份额。北美自体输血设备市场按应用分为心脏手术、骨科手术、器官移植、创伤手术等。 2021 年，心脏手术领域占据最大的市场份额。根据最终用户，市场分为医院、专科诊所和门诊手术中心。 2021 年，医院细分市场占据最大市场份额。根据国家/地区，市场分为美国、加拿大和墨西哥。美国在 2021 年贡献了相当大的份额。
BD、Braile Biomedica、Fresenius SE 和Co. KGaA、Haemonetics Corporation、LivaNova PLC、Medtronic、Redax SpA、SARSTEDT AG and Co. KG、Teleflex Incorporated 和 Zimmer Biomet 是北美自体输血设备市场的领先公司。
Strategic insights for North America Autotransfusion Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 328.30 Million |
| Market Size by 2028 | US$ 448.50 Million |
| Global CAGR (2021 - 2028) | 4.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Autotransfusion Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Autotransfusion Devices Market is valued at US$ 328.30 Million in 2021, it is projected to reach US$ 448.50 Million by 2028.
As per our report North America Autotransfusion Devices Market, the market size is valued at US$ 328.30 Million in 2021, projecting it to reach US$ 448.50 Million by 2028. This translates to a CAGR of approximately 4.6% during the forecast period.
The North America Autotransfusion Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Autotransfusion Devices Market report:
The North America Autotransfusion Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Autotransfusion Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Autotransfusion Devices Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Autotransfusion Devices Market
